E. Peles1 , D. S. Goldstein2, S. Akselrod3, H. Nitzan1, M. Azaria4, S. Almog5, D. Dolphin6, H. Halkin5 and M. Modan1
(1) | Department of Clinical Epidemiology, Chaim Sheba Medical Center, Tel Hashomer, Israel |
(2) | Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA |
(3) | School of Physics and Astronomy, Tel Aviv University, Ramat Aviv, Israel |
(4) | Department of Orthopaedic Rehabilitation, Sheba Medical Centre, Tel Hashomer, Israel |
(5) | Division of Clinical Pharmacology and Toxicology, Sheba Medical Centre, Tel Hashomer, Israel |
(6) | Ministry of Defense, Israel |
Received: 17 January 1995 Accepted: 17 July 1995
Abstract Overstimulation of sympathetic nervous system activity is related to atherosclerotic cardiovascular disease risk, but the role of parasympathetic activity in this association is not clear. This study evaluated sympathetic and parasympathetic function by spectral analysis of heart rate variability and plasma levels of norepinephrine (NE) epinephrine (EPI), dihydroxyphenylglycol (DHPG), dihydroxyphenylalanine (DOPA) and dihydroxyphenylacetic acid (DOPAC).